69 related articles for article (PubMed ID: 19914324)
1. Misleading de novo detection of serum anti-HLA-A3 antibodies in kidney recipients having received ATG before transplantation.
Masson E; Devillard N; Chabod J; Yannaraki M; Thevenin C; Tiberghien P; Rebibou JM
Hum Immunol; 2010 Feb; 71(2):170-5. PubMed ID: 19914324
[TBL] [Abstract][Full Text] [Related]
2. ATG induction is associated with an increase in anti-HLA antibodies after kidney transplantation.
Tinckam KJ; Wood IG; Ji F; Milford EL
Hum Immunol; 2004 Nov; 65(11):1281-7. PubMed ID: 15556678
[TBL] [Abstract][Full Text] [Related]
3. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
Li X; Ishida H; Yamaguchi Y; Tanabe K
Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
[TBL] [Abstract][Full Text] [Related]
4. Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies.
Colovai AI; Vasilescu ER; Foca-Rodi A; Kim-Schulze S; Hussaini N; D'agati VD; Markowitz GS; Wang C; Cohen DJ; Hardy MA; Suciu-Foca N
Hum Immunol; 2005 May; 66(5):501-12. PubMed ID: 15935887
[TBL] [Abstract][Full Text] [Related]
5. The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays.
Gloor JM; Moore SB; Schneider BA; Degoey SR; Stegall MD
Transplantation; 2007 Jul; 84(2):258-64. PubMed ID: 17667819
[TBL] [Abstract][Full Text] [Related]
6. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
7. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
[TBL] [Abstract][Full Text] [Related]
8. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
9. Anti-HLA antibodies in kidney transplanted patients.
Maccarone D; Cervelli C; Parzanese I; Pisani F; Caniglia L; Rascente M; Battistoni C; Famulari A; Adorno D
Transplant Proc; 2005; 37(6):2459-60. PubMed ID: 16182708
[TBL] [Abstract][Full Text] [Related]
10. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
[TBL] [Abstract][Full Text] [Related]
11. [Anti-HLA antibodies after bone graft and their impact on kidney transplant programs].
Mosconi G; Baraldi O; Fantinati C; Cappuccilli ML; Corsini S; Zanelli P; Bassi A; Buscaroli B; Feliciangeli G; Stefoni S
G Ital Nefrol; 2009; 26 Suppl 45():S58-63. PubMed ID: 19382096
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools.
Eng HS; Bennett G; Bardy P; Coghlan P; Russ GR; Coates PT
Hum Immunol; 2009 Aug; 70(8):595-9. PubMed ID: 19527759
[TBL] [Abstract][Full Text] [Related]
13. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
[TBL] [Abstract][Full Text] [Related]
14. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Kröger N; Schetelig J; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Siegert W; Zander AR
Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786
[TBL] [Abstract][Full Text] [Related]
15. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine.
Knight RJ; Kerman RH; Podder H; Katz SM; Van Buren CT; Kahan BD
Transplant Proc; 2005 Mar; 37(2):1280-2. PubMed ID: 15848695
[TBL] [Abstract][Full Text] [Related]
16. Single-shot antithymocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus Thymoglobulin.
Schulz T; Papapostolou G; Schenker P; Kapischke M
Transplant Proc; 2005 Mar; 37(2):1301-4. PubMed ID: 15848703
[TBL] [Abstract][Full Text] [Related]
17. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation.
Seidel MG; Fritsch G; Matthes-Martin S; Lawitschka A; Lion T; Pötschger U; Rosenmayr A; Fischer G; Gadner H; Peters C
Haematologica; 2005 Oct; 90(10):1405-14. PubMed ID: 16219578
[TBL] [Abstract][Full Text] [Related]
19. [Anti-HLA antibodies in nephropathic patients].
Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
[TBL] [Abstract][Full Text] [Related]
20. Anti-HLA alloantibodies in pediatric solid organ transplantation.
Girnita AL; Webber SA; Zeevi A
Pediatr Transplant; 2006 Mar; 10(2):146-53. PubMed ID: 16573598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
